New study tracks nerve pain from breast cancer drug
NCT ID NCT05889988
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 36 people with HER2-positive breast cancer who are receiving the drug T-DM1. Researchers want to learn how often and how severely the drug causes nerve damage (peripheral neuropathy), such as numbness, tingling, or pain. Participants will report their symptoms through questionnaires over time. The goal is to better understand this side effect, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Essentia Health - Deer River Clinic
Deer River, Minnesota, 56636, United States
-
Essentia Health - Fosston
Fosston, Minnesota, 56542, United States
-
Essentia Health - International Falls Clinic
International Falls, Minnesota, 56649, United States
-
Essentia Health - Park Rapids
Park Rapids, Minnesota, 56470, United States
-
Essentia Health Baxter Clinic
Baxter, Minnesota, 56425, United States
-
Essentia Health Cancer Center
Duluth, Minnesota, 55805, United States
-
Essentia Health Ely Clinic
Ely, Minnesota, 55731, United States
-
Essentia Health Hibbing Clinic
Hibbing, Minnesota, 55746, United States
-
Essentia Health Moose Lake
Moose Lake, Minnesota, 55767, United States
-
Essentia Health Saint Joseph's Medical Center
Brainerd, Minnesota, 56401, United States
-
Essentia Health Saint Mary's - Detroit Lakes Clinic
Detroit Lakes, Minnesota, 56501, United States
-
Essentia Health Sandstone
Sandstone, Minnesota, 55072, United States
-
Essentia Health Virginia Clinic
Virginia, Minnesota, 55792, United States
-
Fairview Grand Itasca Clinic & Hospital
Grand Rapids, Minnesota, 55744, United States
-
Fairview Northland Medical Center
Princeton, Minnesota, 55731, United States
-
Fairview Range Medical Center
Hibbing, Minnesota, 55746, United States
-
MMCORC CentraCare Monticello Cancer Center
Monticello, Minnesota, 55362, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
Riverwood Healthcare Center
Aitkin, Minnesota, 56431, United States
-
Sanford Health Thief River Falls Clinic
Thief River Falls, Minnesota, 56701, United States
-
Sanford Health Worthington
Worthington, Minnesota, 56187, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a triple drug combo shrink HER2-Positive breast tumors before surgery?
- Can an extra radiation dose keep HER2+ breast cancer at bay?
- Can a drug cocktail cure metastatic breast cancer? a trial aims to find out
- Can less chemo be enough? a trial challenges standard treatment for HER2-Positive breast cancer
- Can a new drug outsmart resistant breast cancer?
- Can a new targeted drug outperform the current standard for HER2-Positive breast cancer?